Myriad Genetics
MYGN
$18.50
Share price
-0.05%
Change (1 day)
-16.55%
Change (1 year)
Operating Margin for Myriad Genetics (MYGN)
Operating Margin as of April 2024 (TTM): -20.72%
According to Myriad Genetics's latest financial reports and stock price the company's current Operating Margin is -20.72%. At the end of 2022 the company had an Operating Margin of -20.73%.
Operating Margin history for Myriad Genetics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -20.73% | 150.66% |
| 2021 | -8.27% | -76.35% |
| 2020 | -34.97% | |
| 2018 | 15.13% | 172.07% |
| 2017 | 5.56% | -75.18% |
| 2016 | 22.41% | 20.1% |
| 2015 | 18.66% | -47.75% |
| 2014 | 35.71% | -6.15% |
| 2013 | 38.04% | 2.26% |
| 2012 | 37.21% | -6.3% |
| 2011 | 39.71% | 2.24% |
| 2010 | 38.83% | -7.07% |
| 2009 | 41.79% | 187.73% |
| 2008 | 14.52% | -147.81% |
| 2007 | -30.37% | -9.1% |
| 2006 | -33.42% | -31.12% |
| 2005 | -48.51% | -32.34% |
| 2004 | -71.71% | 88.96% |
| 2003 | -37.95% | 51.45% |
| 2002 | -25.06% | 71.68% |
| 2001 | -14.59% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 15.60% | -175.29% | 🇺🇸 USA |
 Exact Sciences EXAS | -30.34% | 46.43% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -123.31% | 🇺🇸 USA |
 Biocept
BIOC | -124.57% | 501.21% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -19.26% | -7.05% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.